Open access
Open access
Powered by Google Translator Translator

Covid-19

AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets. The benefits of the vaccine continue to outweigh the risks for people who receive it.

8 Apr, 2021 | 09:07h | UTC

AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets – European Medicines Agency

Commentaries: In rare instances, AstraZeneca’s Covid-19 vaccine linked to blood clots, regulators say – STAT AND Expert reaction to statements from MHRA and EMA in relation to the AstraZeneca vaccine and rare blood clots and low blood platelets – Science Media Centre

 


JCVI statement on use of the AstraZeneca COVID-19 vaccine: “JCVI currently advises that it is preferable for adults aged <30 years to be offered an alternative COVID-19 vaccine, if available.”

8 Apr, 2021 | 09:02h | UTC

JCVI statement on use of the AstraZeneca COVID-19 vaccine: 7 April 2021 – GOV.UK

Commentaries: Covid: Under-30s offered alternative to Oxford-AstraZeneca jab – BBC AND Expert reaction to statements from MHRA and EMA in relation to the AstraZeneca vaccine and rare blood clots and low blood platelets – Science Media Centre

 


Video: Coronavirus Variants and Vaccines

8 Apr, 2021 | 09:00h | UTC

Coronavirus Variants and Vaccines – JAMA

 


Study finds low risk of venous thromboembolism in outpatients with Covid-19 – researchers advise against the use of anticoagulants outside clinical trials

8 Apr, 2021 | 08:59h | UTC

Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California – JAMA Internal Medicine

Commentaries: VTE Related to SARS-CoV-2 Infection Less Of a Problem in Outpatients – TCTMD AND No Increase Seen in Outpatient VTE for SARS-CoV-2-Positive Patients – Physician’s Weekly

 

Commentary on Twitter (thread – Click for more)

https://twitter.com/gjgeersing/status/1379740743951134721

 


CDC Updated Guidance: “It is possible for people to be infected through contact with contaminated surfaces or objects, but the risk is generally considered to be low”

7 Apr, 2021 | 02:00h | UTC

Science Brief: SARS-CoV-2 and Surface (Fomite) Transmission for Indoor Community Environments – Centers for Disease Control and Prevention

Related: Catching COVID from surfaces is very unlikely. So perhaps we can ease up on the disinfecting – The Conversation AND Coronavirus is in the air — there’s too much focus on surfaces – Nature AND COVID-19 rarely spreads through surfaces. So why are we still deep cleaning? – Nature

 


Differences in susceptibility of circulating SARS-CoV-2 variants B.1.1.7 and B.1.351 to neutralization by convalescent plasma or vaccinee (Sinopharm or Sinovac) serum

7 Apr, 2021 | 01:57h | UTC

Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization – New England Journal of Medicine

Related studies: Another study indicates SARS-CoV-2 variant B.1.351, but not variant B.1.1.7, has partial resistance to neutralizing antibodies generated by natural infection or mRNA vaccination – Nature Medicine AND Pfizer coronavirus vaccine found to be moderately less effective against B.1.351 variant AND SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination AND B.1.351 strain of SARS-CoV-2 neutralization titer reduced 8- to 9-fold for Pfizer and AstraZeneca vaccinees. Convalescent plasma and therapeutic antibodies were less effective against this variant as well. AND RCT: Oxford/AstraZeneca vaccine does not protect against mild-to-moderate Covid-19 due to the B.1.351 variant AND New study of Coronavirus variants predicts virus evolving to escape current vaccines, treatments AND Moderna COVID-19 vaccine may be less effective against variant found in South Africa

 

Commentary on Twitter

https://twitter.com/hildabast/status/1379597338956603400

 


Guidance on syndrome of Thrombosis and Thrombocytopenia occurring after coronavirus Vaccination

7 Apr, 2021 | 01:48h | UTC

Guidance produced from the Expert Haematology Panel (EHP) focussed on syndrome of Thrombosis and Thrombocytopenia occurring after coronavirus Vaccination – British Society of Haematology

Related: Exceedingly rare side effects reported with AstraZeneca vaccine in the UK – 22 cases of cerebral venous sinus thrombosis with low levels of platelets out of 18 million vaccinated individuals

 

Commentary on Twitter

https://twitter.com/trishgreenhalgh/status/1379414362700517385

 


Epidemiology of Multisystem Inflammatory Syndrome in Children: A Step Closer to Understanding Who, Where, and When

7 Apr, 2021 | 01:52h | UTC

Editorial: Epidemiology of Multisystem Inflammatory Syndrome in Children: A Step Closer to Understanding Who, Where, and When – JAMA Pediatrics

Original study: Trends in Geographic and Temporal Distribution of US Children With Multisystem Inflammatory Syndrome During the COVID-19 Pandemic – JAMA Pediatrics

Commentaries: New findings in COVID-related kids’ syndrome, Kawasaki disease – CIDRAP AND Most kids with serious inflammatory illness had mild COVID – Associated Press

 


Opinion | New COVID variants have changed the game, and vaccines will not be enough. We need global ‘maximum suppression’

7 Apr, 2021 | 01:44h | UTC

New COVID variants have changed the game, and vaccines will not be enough. We need global ‘maximum suppression’ – The Conversation

 

Commentary on Twitter

 


Antibody persistence for at least 6 months after the second dose of mRNA vaccine (Moderna) for Covid-19

7 Apr, 2021 | 01:54h | UTC

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 – New England Journal of Medicine

Commentary: Moderna COVID Vaccine Offers Protection for at Least 6 Months: Study – HealthDay

Related: [Press release – not published yet] Pfizer/BioNTech vaccine is 91% effective for at least 6 months

 

Commentary on Twitter

 


What’s the new coronavirus variant in India and how should it change their COVID response?

7 Apr, 2021 | 01:42h | UTC

What’s the new coronavirus variant in India and how should it change their COVID response? – The Conversation

 


Covid-19: Italy makes vaccination mandatory for healthcare workers

7 Apr, 2021 | 01:39h | UTC

Covid-19: Italy makes vaccination mandatory for healthcare workers – The BMJ

 


Large study showed no association between blood group types and increased risk of Covid-19

7 Apr, 2021 | 01:41h | UTC

Association of Sociodemographic Factors and Blood Group Type With Risk of COVID-19 in a US Population – JAMA Network Open

 

Commentary on Twitter

 


CDC Report: Community Transmission of SARS-CoV-2 Associated with a Local Bar Opening Event

6 Apr, 2021 | 01:29h | UTC

Community Transmission of SARS-CoV-2 Associated with a Local Bar Opening Event — Illinois, February 2021 – CDC Morbidity and Mortality Weekly Report

Commentaries: Illinois bar opening event linked to 46 Covid-19 cases, a school closure and hospitalization, CDC report says – CNN AND Bar opening linked to 29 COVID-19 diagnoses among staff and patrons, 17 more across the community affecting school, nursing home – Science Speaks: Global ID News AND 46 COVID-19 cases linked to one indoor bar event in rural Illinois: CDC – The Hill

Related: Why indoor spaces are still prime COVID hotspots – Nature

 


Long Covid Implications for the workplace

6 Apr, 2021 | 01:15h | UTC

Long Covid Implications for the workplace – Occupational Medicine

 


Probable airborne transmission of SARS-CoV-2 in a poorly ventilated restaurant

6 Apr, 2021 | 01:27h | UTC

Probable airborne transmission of SARS-CoV-2 in a poorly ventilated restaurant – Building and Environment

Related: Why indoor spaces are still prime COVID hotspots – Nature

 

Commentary on Twitter (thread – click for more)

 


Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing

6 Apr, 2021 | 01:26h | UTC

Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing, Australia, 2020 – CDC Emerging Infectious Diseases

Related: Why indoor spaces are still prime COVID hotspots – Nature

 

Commentary on Twitter

 


Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines

6 Apr, 2021 | 01:21h | UTC

Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines – JAMA

 

Commentaries on Twitter

 


Covid-19 Has Created Thousands Of Newly Single Parents And Orphans

6 Apr, 2021 | 01:24h | UTC

BREAKING: Covid-19 Has Created Thousands Of Newly Single Parents And Orphans – Brief19

Original study: Estimates and Projections of COVID-19 and Parental Death in the US – JAMA Pediatrics

 

Commentary on Twitter

 


A framework for microbiome science in public health

6 Apr, 2021 | 01:19h | UTC

A framework for microbiome science in public health – Nature Medicine

 


Cohort study: Association between pre-existing respiratory disease and its treatment, and severe COVID-19

6 Apr, 2021 | 01:17h | UTC

Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study – The Lancet Respiratory Medicine

 


U.S. Saw Over 520,000 Excess Deaths in 2020, Most from COVID-19

6 Apr, 2021 | 01:18h | UTC

U.S. Saw Over 520,000 Excess Deaths in 2020, Most from COVID-19 – NEJM Journal Watch

Original study: Excess Deaths From COVID-19 and Other Causes in the US, March 1, 2020, to January 2, 2021 – JAMA

Editorial: Learning From Excess Pandemic Deaths – JAMA

 


Cohort Study: Selected patients with Covid-19 can be safely discharged on home oxygen, with low mortality and readmission rates

5 Apr, 2021 | 01:52h | UTC

Mortality and Readmission Rates Among Patients With COVID-19 After Discharge From Acute Care Setting With Supplemental Oxygen – JAMA Network Open

Video: Home Oxygen Instructions for Discharged Patients With COVID-19

Commentaries: Covid-19: Ambulatory Management with Home Oxygen Results in Low Mortality, Low Readmissions – Physician’s Weekly AND Mortality, readmission low with COVID-19 discharge on home oxygen – HealthDay

 

Commentaries on Twitter

 


How mRNA Technology Could Change the World

5 Apr, 2021 | 01:36h | UTC

How mRNA Technology Could Change the World – The Atlantic (a few articles per month are free)

 


Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries

5 Apr, 2021 | 01:49h | UTC

Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries – The Lancet Respiratory Medicine

Commentary: Criteria for selecting COVID-19 patients for lung lung transplantation – Medical University of Vienna

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.